<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" title="XSL_formatting" href="http://www.mstrust.org.uk/news/rss/rss.xsl"?><rss version="2.0"><channel><title><![CDATA[MS Trust Recent Story List]]></title><link><![CDATA[http://2008.mstrust.org.uk]]></link><description><![CDATA[]]></description><language><![CDATA[en-us]]></language><lastBuildDate><![CDATA[Mon, 15 Mar 2010 13:01:02 +0000]]></lastBuildDate><copyright><![CDATA[Multiple Sclerosis Trust, Spirella Building, Letchworth Garden City, Herts SG6 4ET]]></copyright><docs><![CDATA[http://blogs.law.harvard.edu/tech/rss]]></docs><generator><![CDATA[www.idnet.net]]></generator><ttl><![CDATA[60]]></ttl><item><title><![CDATA[Living with the uncertainty of multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3576]]></link><description><![CDATA[Don't use the words "disease" and "patient" around Jessica Hoar.]]></description><pubDate><![CDATA[Mon, 15 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3576]]></guid></item><item><title><![CDATA[Social care under-funded and rationed, say MPs]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3575]]></link><description><![CDATA[Adult social care in England is "chronically under-funded" and "severely rationed", MPs say.]]></description><pubDate><![CDATA[Fri, 12 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3575]]></guid></item><item><title><![CDATA[Call for employers to be 'carer friendly']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3573]]></link><description><![CDATA[Business, Government and charity leaders today backed better support for staff who balance a job with caring for an older or disabled person.]]></description><pubDate><![CDATA[Thu, 11 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3573]]></guid></item><item><title><![CDATA[The opportunity that wasn't]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3571]]></link><description><![CDATA[Opportunistic infections aren't an opportunity for Roche and Biogen Idec. In fact, they have ocrelizumab, the follow-up to the companies' near-blockbuster Rituxan, on the ropes and headed for a TKO.]]></description><pubDate><![CDATA[Wed, 10 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3571]]></guid></item><item><title><![CDATA[Is pain all in the mind?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3569]]></link><description><![CDATA[New medical technology shows that the best way of treating chronic pain may be with CBT-style brain retraining.]]></description><pubDate><![CDATA[Tue, 9 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3569]]></guid></item><item><title><![CDATA[Risks 'taken' in illegal cord blood collections]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3566]]></link><description><![CDATA[Parents, hospitals and private firms are being warned over risky and illegal collections of umbilical cord blood.]]></description><pubDate><![CDATA[Tue, 9 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3566]]></guid></item><item><title><![CDATA[Botox receives FDA approval for treatment of upper limb spasticity in adults]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3570]]></link><description><![CDATA[Allergan Inc announced that the United States Food and Drug Administration or FDA has approved Botox for treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity.]]></description><pubDate><![CDATA[Tue, 9 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3570]]></guid></item><item><title><![CDATA[Immune system boost from Vitamin D?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3567]]></link><description><![CDATA[<em>The Daily Telegraph</em> has reported that "vitamin D 'triggers and arms' the immune system". It said that researchers believe that vitamin D plays a key role in boosting the immune system.]]></description><pubDate><![CDATA[Mon, 8 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3567]]></guid></item><item><title><![CDATA[Vitamin D 'triggers and arms' the immune system]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3561]]></link><description><![CDATA[Vitamin D is crucial to the fending off of infections, claims new research.
]]></description><pubDate><![CDATA[Sun, 7 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3561]]></guid></item><item><title><![CDATA[Scientists find why "sunshine" vitamin D is crucial]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3562]]></link><description><![CDATA[Vitamin D is vital in activating human defenses and low levels suffered by around half the world's population may mean their immune systems' killer T cells are poor at fighting infection, scientists said on Sunday.]]></description><pubDate><![CDATA[Sun, 7 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3562]]></guid></item><item><title><![CDATA[Success for pilot scheme]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3560]]></link><description><![CDATA[An innovative scheme piloted in Surrey and Sussex, the first of its kind in the country, has had an overwhelmingly positive impact on the lives of people in the area with multiple sclerosis (MS).]]></description><pubDate><![CDATA[Fri, 5 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3560]]></guid></item><item><title><![CDATA['It has absolutely changed my life']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3558]]></link><description><![CDATA[WalkAide device helps woman walk again after paralysis.]]></description><pubDate><![CDATA[Thu, 4 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3558]]></guid></item><item><title><![CDATA[Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3559]]></link><description><![CDATA[First long-term study among individuals not infected with EBV suggests EBV infection likely to be a cause of MS, not a consequence.]]></description><pubDate><![CDATA[Thu, 4 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3559]]></guid></item><item><title><![CDATA[Laws on mobility vehicles to be tightened]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3557]]></link><description><![CDATA[Mobility scooter owners may have to take driving tests and buy compulsory motor insurance under plans being drawn up by the Government.]]></description><pubDate><![CDATA[Wed, 3 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3557]]></guid></item><item><title><![CDATA[Chronic pain is a disease experts argue]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3552]]></link><description><![CDATA[Long-term pain should be seen as a disease in its own right in order for the condition which affects millions to be taken more seriously, researchers said.]]></description><pubDate><![CDATA[Tue, 2 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3552]]></guid></item><item><title><![CDATA[LDN study results published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3555]]></link><description><![CDATA[At long last, the results from the University of California at San Francisco study of low dose naltrexone (LDN) in patients with multiple sclerosis (MS) have been released.]]></description><pubDate><![CDATA[Tue, 2 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3555]]></guid></item><item><title><![CDATA[Stanford University halts CCSVI treatments after two serious incidents]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3556]]></link><description><![CDATA[Researchers at Stanford University have halted treatments for chronic cerebrospinal venous insufficiency (CCSVI) according February's edition of the journal <em>Annals of Neurology</em>.
]]></description><pubDate><![CDATA[Tue, 2 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3556]]></guid></item><item><title><![CDATA[MS trial alert: study of oral teriflunomide (HMR1726) recruiting people at high risk for MS worldwide]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3551]]></link><description><![CDATA[Investigators worldwide are recruiting people at high risk for multiple sclerosis (MS) for a study comparing two doses of oral HMR1726 (teriflunomide), an immune system-modulating agent, and inactive placebo.]]></description><pubDate><![CDATA[Mon, 1 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3551]]></guid></item><item><title><![CDATA[Infection 'could trigger MS in those susceptible to the disease']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3553]]></link><description><![CDATA[An infection could trigger multiple sclerosis in those susceptible to the debilitating disease, a new study suggests.]]></description><pubDate><![CDATA[Sat, 27 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3553]]></guid></item><item><title><![CDATA[Specialist nurse role 'critical to care']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3554]]></link><description><![CDATA[The Royal College of Nursing (RCN) is calling for every patient with a long-term condition to have access to specialist nursing care.]]></description><pubDate><![CDATA[Sat, 27 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3554]]></guid></item><item><title><![CDATA['It's a comfort to have the choice']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3549]]></link><description><![CDATA[Nicky Dalladay leans forward from the sofa to take the occasional sip of squash from a straw, using only her mouth. It is the only immediate sign of her severe multiple sclerosis, which in recent years has confined her to a wheelchair.]]></description><pubDate><![CDATA[Fri, 26 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3549]]></guid></item><item><title><![CDATA[Motivation key over assisted death prosecutions]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3545]]></link><description><![CDATA[New guidelines over whether people would face prosecution over assisting suicide place closer scrutiny on a suspect's motivation.
]]></description><pubDate><![CDATA[Thu, 25 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3545]]></guid></item><item><title><![CDATA[DPP publishes assisted suicide policy]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3548]]></link><description><![CDATA[The public can have full confidence in the policy the CPS will follow in deciding whether or not to prosecute cases of assisted suicide, Keir Starmer QC, Director of Public Prosecutions, said today.]]></description><pubDate><![CDATA[Thu, 25 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3548]]></guid></item><item><title><![CDATA[Call to invest in specialist nurses]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3542]]></link><description><![CDATA[The NHS could save millions of pounds by investing in nurses to support people with conditions like Parkinson's and multiple sclerosis, a union said.]]></description><pubDate><![CDATA[Wed, 24 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3542]]></guid></item><item><title><![CDATA[Cutting specialist nurses could cost NHS millions, warns RCN]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3546]]></link><description><![CDATA[Cutting specialist nursing services for people with long term conditions would be a "false economy" that could cost the NHS millions, the Royal College of Nursing warned today.]]></description><pubDate><![CDATA[Wed, 24 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3546]]></guid></item><item><title><![CDATA[Migraine linked to MS in women]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3539]]></link><description><![CDATA[Women with physician-diagnosed migraine appear to have an increased risk of developing multiple sclerosis (MS), researchers found.]]></description><pubDate><![CDATA[Sun, 21 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3539]]></guid></item><item><title><![CDATA[Villagers find therapeutic riding program alleviates multiple sclerosis symptoms]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3540]]></link><description><![CDATA[To hear their stories, one might initially assume Cindy Berkovitz and Judy Heath wouldn't be physically able to ride a horse. Both women from The Villages have multiple sclerosis and both require the use of an aid - Berkovitz a scooter and Heath a leg brace - to get around.]]></description><pubDate><![CDATA[Sat, 20 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3540]]></guid></item><item><title><![CDATA[Doctors should say what work staff can do instead of signing off sick: ministers]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3535]]></link><description><![CDATA[Doctors should consider what work staff are fit for instead of simply signing them off sick, ministers will say.]]></description><pubDate><![CDATA[Fri, 19 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3535]]></guid></item><item><title><![CDATA[Problem with postal delivery to the MHRA of completed Yellow Cards]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3536]]></link><description><![CDATA[We have identified a problem with the Yellow Card postal delivery service. Some Yellow Cards have been returned to sender due to an error at Royal Mail.]]></description><pubDate><![CDATA[Fri, 19 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3536]]></guid></item><item><title><![CDATA[Studies show marijuana has 'therapeutic value']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3534]]></link><description><![CDATA[Researchers from the University of California's Center for Medicinal Cannabis Research (CMCR) have found "reasonable evidence that cannabis is a promising treatment" for some specific, pain-related medical conditions.
]]></description><pubDate><![CDATA[Thu, 18 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3534]]></guid></item><item><title><![CDATA[Exercise helps protect brain of multiple sclerosis patients]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3533]]></link><description><![CDATA[Highly fit multiple sclerosis patients perform significantly better on tests of cognitive function than similar less-fit patients, a new study shows.]]></description><pubDate><![CDATA[Thu, 18 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3533]]></guid></item><item><title><![CDATA[Lourdes a modest miracle]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3529]]></link><description><![CDATA[Filmed in an austere, near-documentary style, <em>Lourdes</em> takes viewers deep inside one of the world's most popular religious shrines.  Writer-director Jessica Hausner uses a multiple sclerosis patient as a sort of case study to show how the site operates as well as to question the sources of religious faith.]]></description><pubDate><![CDATA[Wed, 17 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3529]]></guid></item><item><title><![CDATA[Drug linked to 35 brain-disease cases]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3525]]></link><description><![CDATA[Biogen Idec Inc's multiple sclerosis drug Tysabri has been linked to four new cases of a life-threatening brain illness, a spokeswoman said.]]></description><pubDate><![CDATA[Tue, 16 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3525]]></guid></item><item><title><![CDATA[Migraine tied to raised multiple sclerosis risk]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3527]]></link><description><![CDATA[But overall odds are still low and headache sufferers shouldn't worry, researcher says.]]></description><pubDate><![CDATA[Tue, 16 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3527]]></guid></item><item><title><![CDATA[Add-on daclizumab may reduce MS disease activity more than interferon beta alone]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3524]]></link><description><![CDATA[Add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standard interferon beta treatment alone, according to a study published online first and appearing in the April edition of <em>The Lancet Neurology</em>.
]]></description><pubDate><![CDATA[Mon, 15 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3524]]></guid></item><item><title><![CDATA[Jimmie Heuga, an early US ski medalist, dies at 66]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3517]]></link><description><![CDATA[Jimmie Heuga, one of the first two American men to win an Olympic medal in Alpine skiing, and later a pioneering advocate of exercise and activity to combat multiple sclerosis, the disease that curtailed his athletic career, died Monday in Boulder, Colo.]]></description><pubDate><![CDATA[Fri, 12 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3517]]></guid></item><item><title><![CDATA[Region handed key role in MS drug trial]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3519]]></link><description><![CDATA[The North-East will be home to one of only three centres in the UK to trial a revolutionary drug for the treatment of primary progressive multiple sclerosis (MS).]]></description><pubDate><![CDATA[Fri, 12 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3519]]></guid></item><item><title><![CDATA[Health and social care services need to be more integrated and personalised says Care Quality Commission]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3522]]></link><description><![CDATA[Services have steadily improved overall but rising demand and pressure on finances make reform essential, says new regulator.]]></description><pubDate><![CDATA[Thu, 11 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3522]]></guid></item><item><title><![CDATA[MS study links narrow veins to disease]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3518]]></link><description><![CDATA[More than half of the multiple sclerosis patients in a closely watched study had narrowing of some neck veins leading from the brain, researchers said.]]></description><pubDate><![CDATA[Thu, 11 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3518]]></guid></item><item><title><![CDATA[Schoolboy's petition prompts move on MS link to vitamin D]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3512]]></link><description><![CDATA[An international conference is to be held in Scotland to discuss the health effects of vitamin D - thanks to the efforts of a 14-year-old schoolboy.]]></description><pubDate><![CDATA[Wed, 10 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3512]]></guid></item><item><title><![CDATA[First blinded study of venous insufficiency prevalence in MS shows promising results]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3514]]></link><description><![CDATA[A study by neurologist Robert Zivadinov has shown that the narrowing of extracranial veins is, at the very least, an important association in multiple sclerosis.]]></description><pubDate><![CDATA[Wed, 10 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3514]]></guid></item><item><title><![CDATA[Blocking cell movement for cancer, multiple sclerosis treatment]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3515]]></link><description><![CDATA[University of Adelaide researchers in Australia are finding new ways to block the movement of cells in the body which can cause autoimmune diseases and the spread of cancer.]]></description><pubDate><![CDATA[Wed, 10 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3515]]></guid></item><item><title><![CDATA[Test theory, but treat MS patients, doctor says]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3504]]></link><description><![CDATA[The Italian doctor behind a controversial new theory of multiple sclerosis said yesterday he welcomes more rigorous scientific investigation of his ideas, but suggested there is no reason MS patients should not immediately undergo the testing and treatment he pioneered.]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3504]]></guid></item><item><title><![CDATA[Doctor says stem cell treatment for MS was 'worth a try' despite no evidence it worked]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3505]]></link><description><![CDATA[A doctor alleged to have administered a stem cell therapy treatment in a ''wholly illegitimate, misleading and dishonest'' way to multiple sclerosis sufferers today told a disciplinary hearing the process in principle was ''worth a try''.]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3505]]></guid></item><item><title><![CDATA[Drinking milk while pregnant may lower kids' MS risk]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3510]]></link><description><![CDATA[Finding suggests that the effect of vitamin D begins in the womb, expert says.]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3510]]></guid></item><item><title><![CDATA[Stem cells 'weren't for human use']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3511]]></link><description><![CDATA[Stem cells supplied to a Dutch clinic where British multiple sclerosis patients went for treatment were not "intended for human use", a General Medical Council hearing has been told.]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3511]]></guid></item><item><title><![CDATA[Woman with MS finds strength, friendship in Pilates sessions]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3495]]></link><description><![CDATA[For the first time in years, Sharon Marchioli is walking down stairs. And she's wearing heels, tapping her right foot, standing up straight - things she thought she had lost to multiple sclerosis.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3495]]></guid></item><item><title><![CDATA[Hamilton researchers to test Italian scientist's MS theory]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3500]]></link><description><![CDATA[Idea that MS is a treatable vascular disease has been controversial.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3500]]></guid></item><item><title><![CDATA[Italian doctor heightens interest in MS cause]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3501]]></link><description><![CDATA[The Italian doctor whose unconventional thinking on the cause of multiple sclerosis is in North America to drum up interest in testing the idea.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3501]]></guid></item><item><title><![CDATA[Study to look at earlier use of MS drug Tysabri]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3503]]></link><description><![CDATA[As regulators once again updated the label on Tysabri over the risk of a rare and potentially fatal brain disease, Biogen Idec and Elan Corp are planning a long-term trial that could lead to use of the multiple sclerosis blockbuster at the early stages of the condition.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3503]]></guid></item><item><title><![CDATA[CCSVI or blood flow in the brain and venous insufficiency in multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3506]]></link><description><![CDATA[February 9th marks the date that the Society receives research grant applications in response to its international request for research proposals.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3506]]></guid></item><item><title><![CDATA[Study of oral teriflunomide (HMR1726) recruiting people with relapsing forms of MS worldwide]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3508]]></link><description><![CDATA[Investigators worldwide are recruiting 1110 people with relapsing forms of multiple sclerosis (MS) for a study comparing two doses of teriflunomide (HMR1726), an investigational, oral MS medication, and inactive placebo.]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3508]]></guid></item><item><title><![CDATA[Blacks with MS have more severe symptoms, decline faster than whites, new study shows]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3494]]></link><description><![CDATA[Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found.]]></description><pubDate><![CDATA[Sat, 6 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3494]]></guid></item><item><title><![CDATA[More doses of MS drug raise risk of brain infection]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3493]]></link><description><![CDATA[FDA adds new warning on Tysabri label, but says benefits still outweigh dangers.]]></description><pubDate><![CDATA[Fri, 5 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3493]]></guid></item><item><title><![CDATA[US warns of risk rise with more Tysabri infusions]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3507]]></link><description><![CDATA[31 cases of serious brain infection confirmed.]]></description><pubDate><![CDATA[Fri, 5 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3507]]></guid></item><item><title><![CDATA[Innovation to be at the heart of care and support services]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3492]]></link><description><![CDATA[A sensor that switches on the lights when you get out of bed, a temperature detector to stop your house getting too hot or too cold and a flood detector are just some of the assistive technologies on display at a state of the art 'wise home' that Phil Hope Care Services Minister visited today in Harrogate.]]></description><pubDate><![CDATA[Thu, 4 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3492]]></guid></item><item><title><![CDATA[Three-quarters of Britons 'suffer from depression']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3481]]></link><description><![CDATA[Three out of four people in the UK suffer from depression at some point but only a third seek help, according to a new poll.]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3481]]></guid></item><item><title><![CDATA[Should we all be taking vitamin D?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3482]]></link><description><![CDATA[It could protect us against colon cancer, improve bone strength and make us happier. Dr Mark Porter asks, 'should we all take Vitamin D?']]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3482]]></guid></item><item><title><![CDATA[Three out of four support change in assisted suicide laws]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3483]]></link><description><![CDATA[Huge public support for a change in the law affecting assisted suicide and euthanasia has been uncovered by a YouGov poll after a succession of high profile court cases.]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3483]]></guid></item><item><title><![CDATA[Gordon Brown receives prescription promise 'wake-up call']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3488]]></link><description><![CDATA[People across England will be joining forces to demonstrate their outrage at Gordon Brown's failure to act on his promise to abolish prescription charges for people with long-term conditions, by taking part in a simultaneous 'wake-up phone call' to No 10.
]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3488]]></guid></item><item><title><![CDATA[Financial lifeline for long-term ill]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3489]]></link><description><![CDATA[An advice service has been launched to help patients coping with long-term illnesses and assist their families in claiming financial support.]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3489]]></guid></item><item><title><![CDATA[Assisted suicide - for and against]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3490]]></link><description><![CDATA[Calls for a change in the law on assisted suicide in England and Wales have reignited the debate on whether the terminally ill should have the right to be helped to die. But who wants what?]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3490]]></guid></item><item><title><![CDATA[Multiple sclerosis risk changes with the season]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3478]]></link><description><![CDATA[Previous studies have shown multiple sclerosis (MS) patients are more often born in spring than in any other season, indicating that there is an environmental risk factor for the disease.]]></description><pubDate><![CDATA[Fri, 29 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3478]]></guid></item><item><title><![CDATA[Lifetime achievement award for Cawston nurse]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3480]]></link><description><![CDATA[A Norfolk nurse has become the first-ever winner of a lifetime achievement award - after her care and commitment inspired its creation.]]></description><pubDate><![CDATA[Fri, 29 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3480]]></guid></item><item><title><![CDATA[Magnetic resonance imaging examined in multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3476]]></link><description><![CDATA[Study evaluates dynamic causal model to assess interactions of brain regions during motor task.]]></description><pubDate><![CDATA[Thu, 28 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3476]]></guid></item><item><title><![CDATA[Breaking the fall]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3474]]></link><description><![CDATA[Information to help MS patients prevent accidents was not available until one nurse took the initiative, writes Mary-Claire Mason.
]]></description><pubDate><![CDATA[Wed, 27 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3474]]></guid></item><item><title><![CDATA[Biogen Idec advances first regenerative MS medicine into human study]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3477]]></link><description><![CDATA[One of the more intriguing experimental drugs for multiple sclerosis has just entered its first clinical trial.]]></description><pubDate><![CDATA[Wed, 27 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3477]]></guid></item><item><title><![CDATA[Give patients guaranteed 24/7 care at the end of life]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3484]]></link><description><![CDATA[The existing commitment to improving care at the end of life must be maintained despite the tough financial times ahead, a report from The King's Fund says.]]></description><pubDate><![CDATA[Wed, 27 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3484]]></guid></item><item><title><![CDATA[Little pill means big news in the treatment of multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3467]]></link><description><![CDATA[A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London.]]></description><pubDate><![CDATA[Tue, 26 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3467]]></guid></item><item><title><![CDATA[Free from pain but not prosecution]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3469]]></link><description><![CDATA[Multiple sclerosis patient Sarah Martin believes cannabis is the best way to liberate herself from the daily pain she endures.]]></description><pubDate><![CDATA[Mon, 25 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3469]]></guid></item><item><title><![CDATA[Two-year results from CLARITY study with cladribine tablets in multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3470]]></link><description><![CDATA[The CLARITY study [published in the <em>New England Journal of Medicine</em>] was a two-year (96-week), randomized, double-blind, placebo-controlled Phase III trial of Cladribine Tablets in 1,326 people with relapsing-remitting multiple sclerosis (MS).
]]></description><pubDate><![CDATA[Sat, 23 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3470]]></guid></item><item><title><![CDATA[Is new MS research the real thing, or a media-driven frenzy?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3471]]></link><description><![CDATA[For long-suffering multiple sclerosis patients, it seemed like a miracle: a relatively simple new explanation for what causes the often-crippling disease, and an equally straightforward fix.]]></description><pubDate><![CDATA[Sat, 23 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3471]]></guid></item><item><title><![CDATA[US approves Acorda MS drug to help with walking]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3468]]></link><description><![CDATA[Ampyra first drug cleared to boost walking speeds in MS - Company says drug should be available in March.]]></description><pubDate><![CDATA[Fri, 22 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3468]]></guid></item><item><title><![CDATA[First tablets to fight multiple sclerosis 'dramatically reduce relapse']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3455]]></link><description><![CDATA[The first tablets to fight multiple sclerosis dramatically reduce the chances of symptoms returning, new studies show.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3455]]></guid></item><item><title><![CDATA[BTG commences phase IIa study of Pleneva for multiple sclerosis - quick facts]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3457]]></link><description><![CDATA[BTG Plc said it commenced dosing in a European multicentre Phase IIa study of Pleneva, a novel orally administered compound under development as a potential treatment for multiple sclerosis.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3457]]></guid></item><item><title><![CDATA[Low vitamin D levels are associated with greater risk of relapse in childhood-onset multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3459]]></link><description><![CDATA[Low vitamin D blood levels are associated with a significantly higher risk of relapse attacks in patients with multiple sclerosis (MS) who develop the disease during childhood, according to a study conducted by researchers from the University of California, San Francisco.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3459]]></guid></item><item><title><![CDATA[European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3460]]></link><description><![CDATA[Risk of PML increases after two years, but benefits of Tysabri continue to outweigh risks for patients with highly active relapsing-remitting multiple sclerosis.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3460]]></guid></item><item><title><![CDATA[European regulators recommend Tysabri label update]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3461]]></link><description><![CDATA[European regulators announce PML cases with Tysabri - Say risk of the brain infection remain low - Recommend updating label to reflect two-year risk.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3461]]></guid></item><item><title><![CDATA[New pills for MS tested]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3462]]></link><description><![CDATA["The first tablets to fight multiple sclerosis dramatically reduce the chances of symptoms returning," <em>The Daily Telegraph</em> has reported.]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3462]]></guid></item><item><title><![CDATA[Hope for MS pill after cladribine and fingolimod trials]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3456]]></link><description><![CDATA[Oral drugs to treat multiple sclerosis could become available in 2011 after promising results in two trials.]]></description><pubDate><![CDATA[Wed, 20 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3456]]></guid></item><item><title><![CDATA[MS pills show promise and risk, studies say]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3458]]></link><description><![CDATA[Tests of the first two oral drugs developed for treating multiple sclerosis show that both cut the frequency of relapses and may slow progression of the disease, but with side effects that could pose a tough decision for patients.]]></description><pubDate><![CDATA[Wed, 20 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3458]]></guid></item><item><title><![CDATA[Foreign clinics making wild claims and growing fears of cancer]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3450]]></link><description><![CDATA[Are stem cells REALLY the miracle we've been promised?]]></description><pubDate><![CDATA[Tue, 19 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3450]]></guid></item><item><title><![CDATA[Young people with MS in film project]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3448]]></link><description><![CDATA[Young people with multiple sclerosis (MS) have been out and about with video cameras in Norwich.]]></description><pubDate><![CDATA[Mon, 18 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3448]]></guid></item><item><title><![CDATA[New ways to treat multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3449]]></link><description><![CDATA[Multiple sclerosis seems to damage the central nervous system at a pace faster than the body's own repair mechanism can keep up. In an attempt to find new approaches to treat the disease, scientists are exploring techniques to give the repair process a boost.]]></description><pubDate><![CDATA[Mon, 18 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3449]]></guid></item><item><title><![CDATA[Have doctors found a cure for MS?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3447]]></link><description><![CDATA[Doctors believe they have cured a British woman of multiple sclerosis after a pioneering operation.]]></description><pubDate><![CDATA[Sun, 17 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3447]]></guid></item><item><title><![CDATA[MS therapy centre nears completion]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3445]]></link><description><![CDATA[The long wait for multiple sclerosis sufferers in Swindon is almost at end - with the unveiling of the new MS therapy centre in sight.
]]></description><pubDate><![CDATA[Fri, 15 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3445]]></guid></item><item><title><![CDATA[UK Stem Cell Foundation & MS Society stem cell research collaboration]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3444]]></link><description><![CDATA[Stem cell research in multiple sclerosis (MS) has been given a much-needed shot in the arm thanks to a partnership between the UK's largest charity supporting people affected by the condition and the UK's only charity dedicated to supporting stem cell research.]]></description><pubDate><![CDATA[Thu, 14 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3444]]></guid></item><item><title><![CDATA[Experimental cancer drugs could offer effective treatments for MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3446]]></link><description><![CDATA[Work on cancer growth and stem cells could reveal ways of reversing damage to the nerves caused by MS.
]]></description><pubDate><![CDATA[Thu, 14 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3446]]></guid></item><item><title><![CDATA[Biogen Idec submits application in Europe for the approval of Fampridine-PR tablets to improve walking ability in people with multiple sclerosis]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3442]]></link><description><![CDATA[Biogen Idec announced the submission of a marketing authorization application (MAA) to the European Medicines Agency for Fampridine Prolonged Release (Fampridine-PR) tablets, a novel oral therapy for the improvement of walking ability in adult patients with multiple sclerosis (MS).]]></description><pubDate><![CDATA[Wed, 13 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3442]]></guid></item><item><title><![CDATA[Could multiple sclerosis by caused by blocked veins?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3440]]></link><description><![CDATA[Five years ago, opera singer Joan Beal had one of those life-changing shocks when her husband Jeff was told he had multiple sclerosis.]]></description><pubDate><![CDATA[Tue, 12 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3440]]></guid></item><item><title><![CDATA[MS carers not alone thanks to new group]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3437]]></link><description><![CDATA[The wife of a Multiple Sclerosis sufferer has set up a special group for partner and carers of people with the disease.]]></description><pubDate><![CDATA[Mon, 11 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3437]]></guid></item><item><title><![CDATA[Stem cell doctor GMC hearing begins]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3438]]></link><description><![CDATA[A doctor offering controversial stem cell treatment is before the GMC today.]]></description><pubDate><![CDATA[Mon, 11 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3438]]></guid></item><item><title><![CDATA[Imagine the most excruciating pain any human being can experience...]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3439]]></link><description><![CDATA[It is said to be one of the worst pains that a human being can experience - so much so, that sufferers have been driven to self-harm or, shockingly, even suicide.]]></description><pubDate><![CDATA[Sat, 9 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3439]]></guid></item><item><title><![CDATA[Patients being tube-fed 'to save time']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3431]]></link><description><![CDATA[Patients are having their health put at risk by staff who feed them through tubes unnecessarily because they are too busy to help them eat normally, a report has warned.]]></description><pubDate><![CDATA[Wed, 6 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3431]]></guid></item><item><title><![CDATA[Four more PML cases in Tysabri users in November]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3433]]></link><description><![CDATA[Total at end of October was 24.  December figure to be released in week or two.]]></description><pubDate><![CDATA[Wed, 6 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3433]]></guid></item><item><title><![CDATA[Investigators in Ohio recruiting 24 people for study of autologous mesenchymal stem cell transplantation]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3435]]></link><description><![CDATA[Investigators in Ohio are recruiting 24 people with relapsing forms of MS for a study of the safety and tolerability of transplanting one's own mesenchymal stem cells (derived from bone marrow).

]]></description><pubDate><![CDATA[Wed, 6 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3435]]></guid></item><item><title><![CDATA[Research into using acupuncture to treat urinary incontinence]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3424]]></link><description><![CDATA[Researchers in America have carried out a pilot study to identify if acupuncture is effective in reducing urinary incontinence and to test research methods for investigating this treatment.]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3424]]></guid></item><item><title><![CDATA[Approval for MS centre near Norwich]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3426]]></link><description><![CDATA[A "groundbreaking" development in healthcare was signalled last night when a dedicated centre for multiple sclerosis patients was approved on the edge of Norwich.]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3426]]></guid></item><item><title><![CDATA[Meditation 'should be routinely available on NHS']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3432]]></link><description><![CDATA[Meditation should be routinely available on the NHS to treat depression, a mental health charity said.]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3432]]></guid></item><item><title><![CDATA[UK faster-access drug scheme "this year"]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3425]]></link><description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) will this month begin a public consultation on proposals to make certain new drugs available to patients before they are formally licensed, with a view to having such a scheme up and running later this year.]]></description><pubDate><![CDATA[Mon, 4 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3425]]></guid></item><item><title><![CDATA[Babies born in April have 'higher MS risk']]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3422]]></link><description><![CDATA[Babies born in April face an increased risk of suffering from multiple sclerosis in later life, possibly as a result of their mothers' lack of exposure to sunlight, according to research.]]></description><pubDate><![CDATA[Sun, 3 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3422]]></guid></item><item><title><![CDATA[Self-efficacy may affect patients' levels of fatigue]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3421]]></link><description><![CDATA[Study suggests psychosocial mechanisms have role in fatigue response to physical activity.]]></description><pubDate><![CDATA[Fri, 1 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3421]]></guid></item><item><title><![CDATA[Eight-month wait for a wheelchair]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3418]]></link><description><![CDATA[A multiple sclerosis sufferer has finally been given a motorised wheelchair after an eight-month wait because the chair was too heavy for the pavement.]]></description><pubDate><![CDATA[Wed, 30 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3418]]></guid></item><item><title><![CDATA[Widely used device for pain therapy not recommended for chronic low back pain]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3420]]></link><description><![CDATA[A new guideline issued by the American Academy of Neurology finds that transcutaneous electric nerve stimulation (TENS), a widely used pain therapy involving a portable device, is not recommended to treat chronic low-back because - pain that has persisted for three months or longer - pain research shows it is not effective.]]></description><pubDate><![CDATA[Wed, 30 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3420]]></guid></item><item><title><![CDATA[Vitamin D can reduce number of falls and fractures in elderly]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3419]]></link><description><![CDATA[Elderly people who take a daily dose of vitamin D can boost their muscle strength and reduce the risk of falls by 19 per cent, according to a new study.]]></description><pubDate><![CDATA[Mon, 28 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3419]]></guid></item><item><title><![CDATA[GWAS meta-analysis supports existence of autoimmune disease clusters]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3417]]></link><description><![CDATA[A new paper in <em>PLoS Genetics</em> today suggests the same genetic variants that increase an individual's risk for one set of autoimmune diseases may actually make them less susceptible to others.]]></description><pubDate><![CDATA[Thu, 24 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3417]]></guid></item><item><title><![CDATA[National MS Society flags CCSVI hypothesis a top research priority in 2010]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3415]]></link><description><![CDATA[As 2009 draws to a close, the National Multiple Sclerosis Society (NMSS) has taken stock of some of the research highlights of the year that was and is looking ahead to 2010.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3415]]></guid></item><item><title><![CDATA[Being ill has turned me into a daredevil]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3409]]></link><description><![CDATA[When Susan Fitzgibbon was diagnosed with multiple sclerosis she decided to make every moment count.]]></description><pubDate><![CDATA[Thu, 17 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3409]]></guid></item><item><title><![CDATA[No one-shot wonder]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3408]]></link><description><![CDATA[IT professional Dave Warden started work in May on an iPhone and iPod Touch application to help multiple sclerosis patients track and analyze their medication schedule. Warden submitted his application to Apple for approval in November, and the product named i-Inject went on sale Dec 6.
]]></description><pubDate><![CDATA[Thu, 17 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3408]]></guid></item><item><title><![CDATA[Physical activity reduces disease-related fatigue and depression by increasing self-efficacy or mastery]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3407]]></link><description><![CDATA[Researchers in the US studying people with chronic diseases found that physical activity may reduce depression and fatigue by increasing self-efficacy, or the belief that one can master physical goals and attain a sense of accomplishment from applying oneself.]]></description><pubDate><![CDATA[Wed, 16 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3407]]></guid></item></channel></rss>
